Literature DB >> 300093

Cefamandole and ampicillin therapy in experimental Haemophilus influenzae meningitis.

L J Strausbaugh, C D Mandaleris, M A Sande.   

Abstract

Cefamandole and ampicillin were compared in the therapy of experimental Haemophilus influenzae meningitis in rabbits. Three dosages of each drug were administered as a continuous intravenous infusion for 8 hr to 24 infected animals. Samples of serum and cerebrospinal fluid (CSF) were obtained at 0, 4, and 8 hr for determination of antibiotic concentrations and bacterial titers in CSF. Serum levels of cefamandole were higher, but CSF concentrations of both antibiotics were similar. With the 60-mg/kg per hr dose, the mean serum level was 106 +/- 61 mug/ml for cefamandole and 58 +/- 32 mug/ml for ampicillin (P less than 0.05). With this dosage the mean level in CSF was 7.3 +/- 8.4 mug/ml for cefamandole and 9.5 +/- 5.4 mug/ml for ampicillin (P = 0.26). The percentage penetration ([concentration in CSF/concentration in serum] X 100%) was higher for ampicillin (mean, 18.8% +/- 8.9%) than for cefamandole (mean, 5.6% +/- 3.8%) with all dosages tested (P less than 0.001). The rate of bacterial killing in vivo during therapy was similar with both drugs. The efficacy of cefamandole and ampicillin given intramuscularly for five days (250 mg every 8 hr) was examined in 42 rabbits. Twelve of 14 untreated control rabbits died within 24-72 hr of inoculation. In contrast, 11 of 14 rabbits treated with cafamandole and 10 of 14 rabbits treated with ampicillin were cured of their infections. Cefamandole compared favorably with ampicillin in the therapy of experimental H. influenzae meningitis.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 300093     DOI: 10.1093/infdis/135.2.210

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  Penetration of cefamandole, cephalothin, and desacetylcephalothin into fibrin clots.

Authors:  M G Bergeron; B M Nguyen; S Trottier; L Gauvreau
Journal:  Antimicrob Agents Chemother       Date:  1977-12       Impact factor: 5.191

Review 2.  Haemophilus influenzae: antibiotic susceptibility.

Authors:  C A Needham
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

3.  Blood, brain, and cerebrospinal fluid concentrations of several antibiotics in rabbits with intact and inflamed meninges.

Authors:  T R Beam; J C Allen
Journal:  Antimicrob Agents Chemother       Date:  1977-12       Impact factor: 5.191

4.  Therapy of serious infections with cefamandole.

Authors:  M F Parry; M J Goldberger; H C Neu
Journal:  Infection       Date:  1978       Impact factor: 3.553

Review 5.  Scope and limitations of experimental chemotherapy.

Authors:  O Zak
Journal:  Experientia       Date:  1980-04-15

6.  Enzyme-linked immunosorbent assay for detection of Streptococcus pneumoniae antigen.

Authors:  S A Harding; W M Scheld; M D McGowan; M A Sande
Journal:  J Clin Microbiol       Date:  1979-09       Impact factor: 5.948

7.  Pharmacokinetics and therapeutic efficacy of imipenem, ceftazidime, and ceftriaxone in experimental meningitis due to an ampicillin- and chloramphenicol-resistant strain of Haemophilus influenzae type b.

Authors:  Y Sakata; G H McCracken; M L Thomas; K D Olsen
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

8.  Pharmacokinetics of cefuroxime in infants and children with bacterial meningitis.

Authors:  M de los A del Rio; D F Chrane; S Shelton; G H McCracken; J D Nelson
Journal:  Antimicrob Agents Chemother       Date:  1982-12       Impact factor: 5.191

9.  Comparison of cefamandole, cephalothin, ampicillin, and chloramphenicol in experimental Escherichia coli meningitis.

Authors:  T R Beam; J C Allen
Journal:  Antimicrob Agents Chemother       Date:  1980-01       Impact factor: 5.191

10.  Pharmacokinetics and bacteriological efficacy of cefoperazone, ceftriaxone, and moxalactam in experimental Streptococcus pneumoniae and Haemophilus influenzae meningitis.

Authors:  G H McCracken; J D Nelson; L Grimm
Journal:  Antimicrob Agents Chemother       Date:  1982-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.